[{"id":"f01e63ff-cabb-4f43-915d-19172e8beeed","acronym":"","url":"https://clinicaltrials.gov/study/NCT02031744","created_at":"2021-01-18T09:19:00.776Z","updated_at":"2024-07-02T16:37:24.418Z","phase":"Phase 3","brief_title":"A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT02031744","lead_sponsor":"Hoffmann-La Roche","biomarkers":" EGFR","pipe":" | ","alterations":" EGFR mutation • MET positive","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • MET positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e erlotinib • onartuzumab (RG3638)"],"overall_status":"Completed","enrollment":" Enrollment 530","initiation":"Initiation: 01/22/2014","start_date":" 01/22/2014","primary_txt":" Primary completion: 01/06/2016","primary_completion_date":" 01/06/2016","study_txt":" Completion: 01/06/2016","study_completion_date":" 01/06/2016","last_update_posted":"2017-03-14"},{"id":"8ff6706a-076e-4c92-932d-088ca0828e2d","acronym":"","url":"https://clinicaltrials.gov/study/NCT01186991","created_at":"2021-01-18T04:44:47.430Z","updated_at":"2024-07-02T16:37:26.364Z","phase":"Phase 2","brief_title":"Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast Cancer","source_id_and_acronym":"NCT01186991","lead_sponsor":"Genentech, Inc.","biomarkers":" HER-2 • ER • PGR","pipe":" | ","alterations":" HER-2 negative","tags":["HER-2 • ER • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Avastin (bevacizumab) • paclitaxel • onartuzumab (RG3638)"],"overall_status":"Completed","enrollment":" Enrollment 185","initiation":"Initiation: 03/01/2011","start_date":" 03/01/2011","primary_txt":" Primary completion: 03/01/2016","primary_completion_date":" 03/01/2016","study_txt":" Completion: 03/01/2016","study_completion_date":" 03/01/2016","last_update_posted":"2017-01-20"}]